Masters of Longevity - The Pulse

MoL Editorial24 Jul 2026
Can Doctors Be Trained for the Longevity Era? (MoL Editorial)

Can Doctors Be Trained for the Longevity Era?

A new global survey suggests that healthy longevity medicine education can change how physicians think and talk about ageing. But the evidence also highlights how much work remains before a rapidly growing field becomes routine clinical care.

PR Newswire24 Jul 2026
AILaminar Pharma Announces "Last Patient, Last Visit" in LAM561 Phase 2b/3 Trial for Newly Diagnosed Glioblastoma Patients (PR Newswire)

Laminar Pharma Announces "Last Patient, Last Visit" in LAM561 Phase 2b/3 Trial for Newly Diagnosed Glioblastoma Patients

A news release announcing completion of patient follow-up in a late-stage clinical trial of an oral membrane lipid therapy for newly diagnosed glioblastoma; read to learn what trial milestone was reached and what next steps and analyses the article previews.

Key takeaways
  • Phase 2b/3 trial reached last patient, last visit with 144 enrolled glioblastoma patients.
  • Topline overall survival results are expected in the second quarter of 2027 after data lock.
  • Safety remained consistent and the LAM561 plus standard of care regimen was well tolerated.
Frontiers - Health24 Jul 2026
AIRecombinant LH priming improves follicular efficiency and pregnancy outcomes in women with diminished ovarian reserve undergoing antagonist IVF stimulation (Fro

Recombinant LH priming improves follicular efficiency and pregnancy outcomes in women with diminished ovarian reserve undergoing antagonist IVF stimulation

Report on using recombinant luteinizing hormone priming with oral contraceptive scheduling to improve ovarian stimulation efficiency and pregnancy outcomes in low-reserve patients.

Key takeaways
  • LH priming reduced cycle suspension before oocyte retrieval from 10.1% to 1.1%.
  • Follicular output rate improved to 59.4% with LH priming versus 52.8% without.
  • Ongoing pregnancy per started cycle rose to 18.3% with LH priming versus 9.4% without.
MoL Event Pick
Longevity Wellness Expo 2026 (Toronto, Canada)

Longevity Wellness Expo 2026

2. OCT 2026 - 4. OCT 2026 - Toronto, CanadaExpo

Toronto expo and conference focused on longevity, wellness, biohacking, health optimization and healthy aging products and services.

Nature - Main24 Jul 2026
Bizarre CRISPR enzyme kills cancer cells by shredding their DNA (Nature - Main)

Bizarre CRISPR enzyme kills cancer cells by shredding their DNA

Covers recent work repurposing an unusual CRISPR enzyme to recognize cancer-cell RNA and trigger catastrophic DNA shredding selectively in malignant cells.

Key takeaways
  • Enzyme can be programmed to recognize a specific messenger RNA, such as one made by a cancer cell.
  • Once the enzyme finds its partner, it slashes the cell’s genome to pieces.
  • Therapy that uses this approach to target head and neck cancers caused by human papillomavirus (HPV).